11:11 AM EDT, 05/31/2022 (MT Newswires) -- Cardio Diagnostics will become a public company through a merger agreement with Mana Capital Acquisition (MAAQ), a blank check firm, according to the companies' joint statement on Tuesday.
The combined business, which will be called Cardio Diagnostics Holdings, is expected to have an equity market capitalization of $175 million and to be listed on Nasdaq under the ticker symbol, "CDIO."
Existing Cardio Diagnostics shareholders will roll all of their equity holdings into the combined business, according to the statement.
The deal is expected to close in the second half of the year, subject to regulatory and stockholder approvals and other conditions.
Price: 9.92, Change: -0.02, Percent Change: -0.20